US FDA designates ‘Breakthrough’ tag to Indian device for cancer care

anti-cancer kit

The US Food and Drug Administration (FDA) has designated a path breaking cancer-treating device, developed by the Bengaluru-based scientist as a ‘breakthrough device’.


The Center for Devices and Radiological Health has apparently found the device extremely beneficial in the treatment of liver, liver, and breast cancers. The device called Cytotron, provides non-invasive tissue engineering that can help treat solid tumours. It is also found to be useful in pain relief and palliative care.

Based on quantum magnetic resonance therapy (QMRT), the device was invented after 30 years of research into cellular pathway by scientist Dr Rajah Vijay Kumar at the Centre for Advanced Research and Development, headquartered in Bhopal.

“We are pleased to inform you that your device and proposed indication for use meet the criteria and have been granted designation as a breakthrough device,” states a communique from the FDA wing to Shreis Scalene Sciences, the company that had taken the device to the US.


“It is indicated for treating protein-linked, abnormally regenerating disorders such as neoplastic disease, and allowing extended progression free survival, with pain palliation, improved quality and dignity of life,” says the letter as quoted by the Times of India.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top